PrEP (HIV pre-exposure prophylaxis) and its possibilities for clinical practice

Nicholls, Emily Jay; Rosengarten, Marsha

doi:10.1177/1363460719886556

Cited by 13 publications

(11 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Such a community may have been more supportive of PrEP use, and at the same time, through a shared sense of community, PrEP disclosure and advocacy may have further strengthened community building. The introduction of PrEP may have also led to opportunities for opening up the conversation about such prevention fatigue and to be responsive to particular needs, such as combining sex and drugs (Nicholls & Rosengarten, 2020; Race, 2017). Furthermore, it should be noted that Belgium and the Netherlands (the focus of this study) are countries with relatively good LGBTI‐friendly policies (ILGA‐Europe, 2020), where MSM experience less gay‐related verbal discrimination or physical violence (Ross et al, 2013), and report less internalised homonegativity (Tran et al, 2018), when compared with other European countries.…”

Section: Discussionmentioning

confidence: 99%

The social meanings of PrEP use – A mixed‐method study of PrEP use disclosure in Antwerp and Amsterdam

Reyniers

Zimmermann

Davidovich

et al. 2021

Sociology Health & Illness

View full text Add to dashboard Cite

Pre‐Exposure Prophylaxis (PrEP) is a novel HIV prevention tool. PrEP stigma is a frequently reported barrier, while social disclosure of PrEP use may be an important facilitator. We explored how PrEP users managed PrEP use disclosure using a symbolic interactionist approach. We interviewed 32 participants from two PrEP demonstration projects (Be‐PrEP‐ared, Antwerp; AMPrEP, Amsterdam). We validated qualitative findings through Be‐PrEP‐ared questionnaire data. A minority of participants had received negative reactions on PrEP. The way PrEP use was disclosed was highly dependent on the social situation. In a sexual context among MSM, PrEP use was associated with condomless sex. Friends endorsed PrEP use as a healthy choice, but also related it to carelessness and promiscuity. It was seldom disclosed to colleagues and family, which is mostly related to social norms dictating when it is acceptable to talk about sex. The study findings reveal that PrEP stigma experiences were not frequent in this population, and that PrEP users actively manage disclosure of their PrEP user status. Frequent disclosure and increased use may have helped PrEP becoming normalised in these MSM communities. To increase uptake, peer communication, community activism and framing PrEP as health promotion rather than a risk‐reduction intervention may be crucial.

show abstract

Section: Discussionmentioning

confidence: 99%

The social meanings of PrEP use – A mixed‐method study of PrEP use disclosure in Antwerp and Amsterdam

Reyniers

Zimmermann

Davidovich

et al. 2021

Sociology Health & Illness

View full text Add to dashboard Cite

show abstract

“…Associated with the emergence of this new patient in healthcare systems, new roles are also being created by PrEP, particularly in physicians' activities (Nicholls and Rosengarten 2020). If they are not already followed in an MSM medical centre, people asking for PrEP are often referred to a health community centre because of the specificity of the indication for this drug, as HIV was usually prevented with non-drug-based tools before PrEP.…”

Section: Pre-exposure Prophylaxis: Hiv-negative Patients and New Meanings Of Arvsmentioning

confidence: 99%

Merging care and prevention: preventive properties of antiretroviral drugs and HIV chronification in the case of Switzerland

Genre

Panese

2021

Anthropology & Medicine

View full text Add to dashboard Cite

Medication is closely involved in the subjective experience of chronic diseases, but also in the chronification process of illnesses which is described in this paper in the specific case of HIV. The development of antiretroviral drugs (ARVs) and the progressive recognition of their potential dual use as treatment as prevention (TasP) and pre-exposure prophylaxis (PrEP) reshape the experience of HIV and its transmission. Acknowledging the importance of a socioanthropological approach to drugs, this paper highlights how therapeutic strategies of treatment and prevention currently shape the process of HIV chronification and its experience for people concerned with ARVs in Switzerland, whether they are seropositive patients on lifelong treatment or seronegative people affected by the preventive properties of drugs.

show abstract

“…The individualization of responsibility not only for health but also for risk (Thomann, 2018 ; Nicholls and Rosengarten, 2019 ) is a conspicuous example of how pharmaceuticalization and neoliberalism are inextricably intertwined. In reference to the popular PrEP campaign implemented in the NYC in 2015 that encouraged gay men of color to “stay sure” and “play sure,” Thomann ( 2018 ) discussed the pharmaceuticalized neoliberal sexual actor who must assume exclusive responsibility for his sexual health.…”

Section: Preventing Hiv At the Cost Of $24000mentioning

confidence: 99%

Pathopolitics: Pathologies and Biopolitics of PrEP

Atuk

2020

Front. Sociol.

View full text Add to dashboard Cite

This paper unveils the pathologies that are produced and sustained by the pharmaceutical industry, specifically by Gilead Sciences, Inc. Broadly defined, pathopolitics is the politics of treating and/or reproducing pathologies. This paper examines pathopolitics in the context of PrEP, or pre-exposure prophylaxis, an antiretroviral medicine that prevents HIV transmission. Although Gilead promises to prevent a pathology through PrEP, it reproduces social and biological pathologies by exposing certain people to higher risks of infections and diseases, thus epitomizing the operating logic of the pharmaceutical industry: that life is protected only insofar as it offers surplus economic and social value. This essay raises three fundamental sets of questions: (1) What are the techniques and mechanics of pathopolitics? (2) How does the pharmaceutical industry produce and exploit surplus value? (3) What is the nature of the relationship between the pharmaceutical citizenship and pathopolitics?

show abstract

PrEP (HIV pre-exposure prophylaxis) and its possibilities for clinical practice

Cited by 13 publications

References 33 publications

The social meanings of PrEP use – A mixed‐method study of PrEP use disclosure in Antwerp and Amsterdam

The social meanings of PrEP use – A mixed‐method study of PrEP use disclosure in Antwerp and Amsterdam

Merging care and prevention: preventive properties of antiretroviral drugs and HIV chronification in the case of Switzerland

Pathopolitics: Pathologies and Biopolitics of PrEP

Contact Info

Product

Resources

About